Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Shares Moving to Nasdaq

NEW YORK (GenomeWeb) – Transgenomic today said that its common shares have been approved for uplisting to the Nasdaq Capital Market.

Its shares, which are currently listed on the OTC Bulletin Board under ticker symbol "TBIO," will start trading on the Nasdaq on May 9 under the same ticker symbol.

"We believe that trading on the Nasdaq market will expand our visibility and provide us access to a broader investor base, helping us translate our strategic growth initiatives and renewed focus on implementation into increased shareholder value going forward," Transgenomic President and CEO Paul Kinnon said in a statement.

The company filed with Nasdaq in January to have its shares listed on the exchange.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.